BUDESONIDE- budesonide spray, metered 
Amerisource Bergen

----------

Drug Facts

Active ingredient (in each spray)

Budesonide (glucocorticoid) 32 mcg

Purpose

Nasal allergy symptom reliever

Uses

Temporarily relieves these symptoms of hay fever or other upper respiratory allergies:

• nasal congestion • runny nose • itchy nose • sneezing

Warnings

Do not use

  • in children under 6 years of age
  • if you have ever had an allergic reaction to any of the ingredients

Ask a doctor before use if you

  • have had recent nose ulcers or nose surgery
  • have had a nose injury that has not healed
  • are using a steroid medicine for asthma, allergies or skin rash
  • have an eye infection
  • have or had glaucoma or cataracts

When using this product

  • the growth rate of some children may be slower
  • some symptoms may get better on the first day of treatment. It may take up to two weeks of daily use to feel the most symptom relief.
  • do not share this bottle with anyone else as this may spread germs
  • remember to tell your doctor about all the medicines you take, including this one

Stop use and ask a doctor if

  • you have, or come into contact with someone who has, chickenpox, measles or tuberculosis
  • you have or develop symptoms of an infection such as persistent fever
  • you have any change in vision
  • you have severe or frequent nosebleeds

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Directions

Read insert (inside package) on how to:

ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER

adults and children 12 years of age and older

  • once daily, spray 2 times into each nostril while sniffing gently
  • once your allergy symptoms improve, reduce to 1 spray in each nostril per day
CHILDREN 6 TO UNDER 12 YEARS OF AGE
  • the growth rate of some children may be slower while using this product. Talk to your child’s doctor if your child needs to use the spray for longer than two months a year
children 6 to under 12 years of age
  • an adult should supervise use
  • once daily, spray 1 time into each nostril while sniffing gently
  • if allergy symptoms do not improve, increase to 2 sprays in each nostril per day. Once allergy symptoms improve, reduce to 1 spray in each nostril per day
children under 6 years of age
  • do not use

  • do not use more than directed
  • if you forget a dose, do not double the next dose
  • do not spray into eyes or mouth
  • if allergy symptoms do not improve after two weeks, stop using and talk to a doctor
  • do not use for the common cold
  • shake well before each use

Other information

Inactive ingredients

carboxymethyl cellulose sodium, dextrose anhydrous, edetate disodium dihydrate, hydrochloric acid (for pH adjustment), microcrystalline cellulose, polysorbate 80, potassium sorbate, purified water

Questions or comments?

call toll free 1-800-706-5575

Principal Display Panel - Carton

CARTON LABEL - PRINCIPAL DISPLAY PANEL - 32 mcg per spray

Amerisource Bergen NDC 46122-389-76

Budesonide Nasal Spray

Allergy Spray

120 sprays

Relief of:

Carton-label

Principal Display Panel - Bottle

BOTTLE LABEL - PRINCIPAL DISPLAY PANEL - 32 mcg per spray

Amerisource Bergen NDC 46122-389-76

Budesonide Nasal Spray

Allergy Spray

120 sprays

Bottle-label

BUDESONIDE 
budesonide spray, metered
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:46122-389
Route of AdministrationNASAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BUDESONIDE (UNII: Q3OKS62Q6X) (Budesonide - UNII:Q3OKS62Q6X) BUDESONIDE32 ug
Inactive Ingredients
Ingredient NameStrength
EDETATE DISODIUM (UNII: 7FLD91C86K)  
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED (UNII: K679OBS311)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
DEXTROSE, UNSPECIFIED FORM (UNII: IY9XDZ35W2)  
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
HYDROCHLORIC ACID (UNII: QTT17582CB)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:46122-389-761 in 1 BOTTLE, SPRAY09/15/2016
1120 in 1 BOTTLE, SPRAY; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA07894909/15/2016
Labeler - Amerisource Bergen (007914906)
Registrant - Apotex Inc. (209429182)
Establishment
NameAddressID/FEIBusiness Operations
Apotex Inc.255092496analysis(46122-389) , manufacture(46122-389)

Revised: 12/2023
Document Id: ad00cf96-8698-0af0-ee8a-523d9adf13b0
Set id: ab2e6644-912c-7d39-8ee4-039152ee3db2
Version: 6
Effective Time: 20231213
 
Amerisource Bergen